Pfizer has initiated a US only
recall of one lot of 30-count
Effexor XR (venlafaxine HCl) 150
mg extended-release capsules,
one lot of 90-count Effexor XR
(venlafaxine HCl) 150 mg extendedrelease
capsules and one lot of
90-count Greenstone LLC-branded
Venlafaxine HCl 150 mg extendedrelease
capsules.
According to Business Wire, the
recall was undertaken because of a
pharmacist report that one bottle
of Pfizer’s Effexor XR contained
one capsule of Tikosyn (dofetilide)
0.25mg in addition to the Effexor XR
capsules, each batch of which was
assembled on the same line.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Mar 14
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.